Immunome (IMNM) Return on Sales (2023 - 2025)
Historic Return on Sales for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to 24.2%.
- Immunome's Return on Sales fell 68400.0% to 24.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.2%, marking a year-over-year increase of 71400.0%. This contributed to the annual value of 33.82% for FY2024, which is 260100.0% down from last year.
- Per Immunome's latest filing, its Return on Sales stood at 24.2% for Q3 2025, which was down 68400.0% from 11.58% recorded in Q2 2025.
- Immunome's 5-year Return on Sales high stood at 1.3% for Q3 2023, and its period low was 128.57% during Q1 2024.
- Over the past 3 years, Immunome's median Return on Sales value was 16.92% (recorded in 2024), while the average stood at 24.86%.
- Its Return on Sales has fluctuated over the past 5 years, first plummeted by -1266800bps in 2024, then soared by 1133200bps in 2025.
- Quarter analysis of 3 years shows Immunome's Return on Sales stood at 24.74% in 2023, then dropped by -22bps to 30.3% in 2024, then rose by 20bps to 24.2% in 2025.
- Its Return on Sales was 24.2% in Q3 2025, compared to 11.58% in Q2 2025 and 15.25% in Q1 2025.